drugset / Trial / NCT00259935
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the bioequivalence of the new oral capsule formulation to the currently used oral capsule formulation of topotecan.
Timeline
- Start
- 2004-10-04
- Primary completion
- 2007-07-05
- Completion
- 2007-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topotecan | Small molecule | 4 mg | Oral |